its a medically supervised procedure
Diabetes Care 2024;47(Suppl
Protecting your hair if you restart or change GLP-1 medications Switching from one GLP-1 medication to another, or restarting after a break, carries a theoretical risk of triggering another round of telogen effluvium, particularly if the new medication or restart leads to another phase of rapid weight loss
Experimental design After 20 days of growth, tissue culture plantlets were divided into five groups for experimental treatment: (1) T0 (untreated), (2) Cd48 (48 h of growth following the addition of 500 mol/L of CdCl 2 to MS solution), (3) GSH48 (48 h of growth following the addition of 500 mol/L of CdCl 2 and 400 mol/L of GSH to MS solution), (4) Cd96 (96 h of growth following the addition of 500 mol/L of CdCl 2 to MS solution), and (5) GSH96 (96 h of growth following the addition of 500 mol/L of CdCl 2 and 400 mol/L of GSH to MS solution)
By this point, purging should have resolved or significantly improved